Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Parkinson's disease.

¹Department of Neurology, University of California, San Francisco 94143-0114, USA.

Neurologic Clinics

|July 27, 2001

Summary

Recent Parkinson's disease management advances include new pharmacotherapy and interventional procedures. While neuroprotective agents show promise, their clinical relevance for slowing Parkinson's disease progression is still under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Changes in the thalamus in atypical parkinsonism detected using shape analysis and diffusion tensor imaging.

AJNR. American journal of neuroradiology·2013

Same author

Fall frequency and risk assessment in early Parkinson's disease.

Parkinsonism & related disorders·2012

Same author

Trends in American Board of Psychiatry and Neurology specialties and neurologic subspecialties.

Neurology·2010

Same author

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Neurology·2009

Same author

Invited article: The ABPN maintenance of certification program for neurologists: past, present, and future.

Neurology·2008

Same author

Recommendations for the clinical use of somatosensory-evoked potentials.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2008

Area of Science:

Neurology
Pharmacology
Neurosurgery

Background:

Parkinson's disease management has evolved significantly.
Advances in pharmacotherapy and surgical interventions are key drivers of change.

Purpose of the Study:

To review current therapeutic strategies for Parkinson's disease.
To evaluate the role of new pharmacotherapies and interventional procedures.
To discuss the potential of neuroprotective agents and surgical options.

Main Methods:

Review of recent literature on Parkinson's disease treatments.
Analysis of pharmacotherapeutic advancements.
Summary of interventional procedures, including surgery and stimulation.

Main Results:

New pharmacotherapies offer improved symptomatic management.
Interventional procedures like ablative surgery and deep brain stimulation provide therapeutic benefits.
Neuroprotective agents are currently of academic interest, lacking established clinical relevance for disease modification.

Conclusions:

Current Parkinson's disease treatment emphasizes pharmacotherapy and interventional procedures.
The clinical utility of neuroprotective agents for slowing disease progression remains to be determined.
Surgical and stimulation techniques offer valuable management options with specific benefits and limitations.

Related Experiment Videos